3 August 2021 in The Anatolian Journal of Cardiology
The study aimed to investigate the predictive power of serum corin levels for distinguishing between hypertensive urgency (HU) and hypertensive emergency (HE) in patients with hypertensive crisis (HC) admitted to the emergency department. A total of 120 consecutive consenting adult patients diagnosed with HC and 55 age- and sex-matched healthy controls were enrolled. Blood pressure measurements [(systolic, diastolic, and mean arterial pressure (MAP)] and the evidence of end-organ damage at the first admission were recorded. Patients with HC were classified as patients with HE or HU according to the presence or absence of acute end-organ damage. Serum corin levels were compared between the 2 groups. The mean serum corin level was significantly lower in the HC group than in the control group; it was also lower in the HE group than in the HU group (p<0.001 for all). In the HE group, clinical features associated with end-organ damage included ST-elevation myocardial infarction (n=28, 46.7%), hemorrhagic stroke (n=11, 18.3%), ischemic stroke (n=11, 18.3%), and non–ST-elevation myocardial infarction (n=10, 16.7%). The receiving operator characteristic (ROC) analysis identified a serum corin cutoff value of 45 pg/mL for distinguishing patients with HE from patients with HU with 98.3% sensitivity and 95% specificity. Our findings suggest that serum corin levels play an important role in regulating blood pressure and are involved in the pathogenesis of HC. Low serum corin levels may predict end-organ damage and serve as a guide for diagnostic decision making in patients with HC.
16 January 2026 in Genel Tıp Dergisi
Aim: This study aims to compare estimated Glomerular Filtration Rate (eGFR) values calculated using Jaffe and enzymatic creatinine measurement methods across different stages of chronic kidney disease (CKD), to assess the impact of these methods on CKD staging, and to evaluate the applicability of the enzymatic method as a reflective test.Materials and Methods: A total of 176 CKD patients were prospectively analyzed. Serum creatinine levels were measured using both Jaffe and enzymatic methods, and eGFR was calculated using the 2021 CKD-EPI formula. Correlation between methods was assessed using Spearman’s test, differences via Bland–Altman analysis, and staging agreement using Cohen’s Kappa.Results: A significant positive correlation was found between the two methods (Spearman’s rho = 0.986; p < 0.001). It was observed that eGFR values calculated using the Jaffe method led to misclassification in 39.4% of cases, particularly in stage G3a. Stage mismatch was detected in 27.3%, 20%, and 27.8% of cases in stages G3b, G4, and G5, respectively. Overall, 23.26% of patients were assigned to different stages.Conclusions: The creatinine measurement method is not only analytical but also a critical factor that directly influences clinical decisions. In particular, different staging using the Jaffe method is common in patients with moderate CKD (G2–G3a). The application of the enzymatic method as a reflective test may be effective in preventing these deviations. Therefore, it is recommended that reflective test algorithms be integrated into laboratory workflows and that the creatinine measurement method used be reflected in the eGFR interpretation.